Stay updated with breaking news from Jonathan Yen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BEACON Trial of BEAM-101 in Sickle Cell Disease Progressing with Consented Patients Projected to Fill Sentinel Cohort and to Initiate Expansion Cohort First Patient Consented in Phase 1/2 Trial of...
The study explores how Gene therapy that modifies haemoglobin can help in treating sickle cell disease and beta thalassemia. | Health
Adenosine base editing restarted fetal hemoglobin expression in cells from patients with sickle cell disease. Find how St. Jude & Broad are advancing to a cure.
Prime-edited hematopoietic stem cells from sickle cell disease patients can engraft and help treat genetic blood disorders in mice.
New study from St. Jude Children's, MIT and Harvard shows a promising approach to treating sickle cell disease.